Health TrialsbyHealthPanel

Evaluation of Fertitonex Effects on Semen Parameters in Clinical Varicocele Patient.

ConditionVaricocele
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18+
SponsorMenoufia University

About this trial

The aim of the study is to evaluate the Fertitonex effects on semen parameters in clinical varicocele patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Primary infertility.

Abnormal semen analysis parameters.

Clinically evident varicocele confirmed by scrotal duplex.

Disqualifiers

2ry infertility.

Normal semen analysis parameters.

Clinically non-evident varicocele.

Past history of varicocelectomy.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Fertitonex capsule

    Drug

    Fertitonex which contains L- carnitine L-tartarate 300 mg, L-arginine 241mg, vitamin B6 1.1 mg, vitamin B12 1.7 mcg, vitamin D3 2 mcg, vitamin E 6.5 mg, vitamin C 60 mg, selenium 28 mcg, zinc 7.5 mg, folic acid 300 mcg and CoQ 10 enzyme 7.5 mg in each capsule. The dose will be one capsule twice daily for 3 months.

  • Placebo Oral Capsule

    Drug

    placebo oral capsule. the dose is twice daily for 3 months

Treatment groups

110 Participants
are divided into 2 treatment groups
Group A: Fertitonex groupActive comparator 1 intervention
Group B: Placebo groupPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Total sperm count

Total sperm count will be assessed by Semen analysis done after 3 months of either fertitonex or placebo administration. Total sperm count will be measured by number of sperms present in the semen sample.

Time frame
3 months
2

Sperm motility

Sperm motility will be assessed by semen analysis done after 3 months of either fertitonex or placebo administration. Both total motility will be measured by percentage of motile sperms and progressive motility will be measured by percentage of progressively motile sperms present in the semen sample.

Time frame
3 months
3

Sperm Morphology

Sperm morphology will be assessed by semen analysis done after 3 months of either fertitonex or placebo administration. Sperm morphology will be measured by percentage of normally shaped sperms present in the semen sample.

Time frame
3 months

Secondary outcomes

Other outcomes

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Menoufia Faculty of MedicineRecruiting32511, Shebin El-Kom, MenoufiaEgyptEgypt

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Menoufia University

Lead sponsor

Source ClinicalTrials.gov
Apply now